This Canadian ultrarunner is still beating athletes 30 and 40 years his junior at the age of 67, and he admits that his diet plays a pivotal role in such success ...
NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...
Massachusetts General Hospital received $655 million in funding from the National Institutes of Health in fiscal 2024 — a slight decrease from the $675 million it secured in 2023, yet it remained the ...